SCHEMBL26445605

SCHEMBL26445605

Cc1cccc(-c2ccc(S(C)(C)C)cc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP3 O14638 2/20 0.46
MMP1 P03956 1/20 0.46
MMP2 P08253 1/20 0.46
MMP3 P08254 1/20 0.46
MMP7 P09237 1/20 0.46
MMP9 P14780 1/20 0.46
MMP8 P22894 1/20 0.46
MMP13 P45452 1/20 0.46
MMP14 P50281 1/20 0.46
ACHE P22303 1/20 0.44
CA2 P00918 2/20 0.44
CA1 P00915 1/20 0.44
CA12 O43570 1/20 0.44
CA9 Q16790 1/20 0.44
PGR P06401 1/20 0.42
HSD17B1 P14061 1/20 0.42
HSD17B2 P37059 1/20 0.42
FNTA P49354 1/20 0.41
FNTB P49356 1/20 0.41
KCNH2 Q12809 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21795330 0.88 ENPP3 (0.46) ENPP3MMP1MMP2MMP3MMP7
SCHEMBL6561397 0.84 ACHE (0.61) ENPP3ACHEPGRHSD17B1HSD17B2
SCHEMBL25490780 0.84 PTGS2 (0.53) MMP1MMP2MMP3MMP7MMP9
SCHEMBL18797759 0.82 ACHE (0.65) ENPP3ACHEPGRHSD17B1HSD17B2
SCHEMBL23003863 0.80 ACHE (0.55) ENPP3ACHEPGRHSD17B1HSD17B2
SCHEMBL29057032 0.80 ACHE (0.55) ENPP3ACHEPGRHSD17B1HSD17B2
SCHEMBL20689786 0.80 TSHR (0.55) ENPP3ACHEPGRHSD17B1HSD17B2
SCHEMBL5545442 0.80 ACHE (0.55) ENPP3ACHEPGRHSD17B1HSD17B2
SCHEMBL29929976 0.80 ACHE (0.55) ENPP3ACHEPGRHSD17B1HSD17B2
SCHEMBL30493472 0.80 ACHE (0.55) ENPP3ACHEPGRHSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11641775-B2 Compounds and organic electronic devices MERCK PATENT GMBH (DE) 2023-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11641775-B2 Compounds and organic electronic devices ETV6, CYP2C19, AFF2 ENPP3 302/4885MMP1 4778/4885MMP2 4871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.